| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.798 | 0.004 | 0.798 | Anticonvulsant | 0.736 0.005 CID_3081 | ||
| 0.774 | 0.001 | 0.774 | Mineralocorticoid receptor antagonist | 0.548 0.003 CID_3081 | ||
| 0.685 | 0.005 | 0.685 | Cardiotonic | 0.549 0.011 CID_3081 | ||
| 0.532 | 0.004 | 0.532 | Glutamate (mGluR) agonist | 0.353 0.005 CID_3081 | ||
| 0.533 | 0.04 | 0.533 | Analgesic | 0.322 0.125 CID_3081 | ||
| 0.498 | 0.051 | 0.864 | Cyclophilin D inhibitor | 0.864 0.005 CID_3081 | CID_3081 | |
| 0.469 | 0.035 | 0.469 | GABA C receptor rho-3 antagonist | 0.46 0.038 CID_3081 | ||
| 0.332 | 0.026 | 0.413 | RNA-directed DNA polymerase inhibitor | 0.413 0.017 CID_3081 | CID_3081 | |
| 0.377 | 0.094 | 0.494 | 5 Hydroxytryptamine release inhibitor | 0.494 0.034 CID_3081 | CID_3081 | |
| 0.282 | 0.005 | 0.282 | Glutamate receptor agonist | 0.132 0.023 CID_3081 | ||
| 0.27 | 0.028 | 0.27 | Diuretic | 0.18 0.054 CID_3081 | ||
| 0.245 | 0.014 | 0.26 | Ferrochelatase inhibitor | 0.26 0.012 CID_3081 | CID_3081 | |
| 0.274 | 0.061 | 0.274 | 5 Hydroxytryptamine uptake stimulant | 0.254 0.077 CID_3081 | ||
| 0.352 | 0.148 | 0.418 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.418 0.086 CID_3081 | CID_3081 | |
| 0.206 | 0.005 | 0.278 | Bromodomain-containing protein 4 inhibitor | 0.278 0.004 CID_3081 | CID_3081 | |
| 0.313 | 0.117 | 0.332 | Histamine release inhibitor | 0.332 0.108 CID_3081 | CID_3081 | |
| 0.257 | 0.062 | 0.265 | Tyrosine 3 hydroxylase inhibitor | 0.265 0.055 CID_3081 | CID_3081 | |
| 0.198 | 0.008 | 0.247 | Phosphodiesterase 3A inhibitor | 0.247 0.005 CID_3081 | CID_3081 | |
| 0.204 | 0.016 | 0.204 | Cathepsin G inhibitor | 0.123 0.026 CID_3081 | ||
| 0.19 | 0.004 | 0.19 | Glutamate (mGluR group II) agonist | |||
| 0.184 | 0.004 | 0.184 | Glutamate (mGluR2) agonist | |||
| 0.215 | 0.041 | 0.239 | 5 Hydroxytryptamine 3E antagonist | 0.239 0.022 CID_3081 | CID_3081 | |
| 0.203 | 0.033 | 0.281 | Alpha-N-acetylglucosaminidase inhibitor | 0.281 0.018 CID_3081 | CID_3081 | |
| 0.241 | 0.073 | 0.332 | DNA synthesis inhibitor | 0.332 0.034 CID_3081 | CID_3081 | |
| 0.271 | 0.114 | 0.276 | Vasodilator, coronary | 0.276 0.109 CID_3081 | CID_3081 | |
| 0.162 | 0.005 | 0.162 | Aldosterone antagonist | 0.106 0.008 CID_3081 | ||
| 0.218 | 0.061 | 0.218 | Neurotrophic factor enhancer | 0.202 0.075 CID_3081 | ||
| 0.226 | 0.07 | 0.226 | Peptidyltransferase inhibitor | |||
| 0.166 | 0.016 | 0.166 | Ca2+-transporting ATPase inhibitor | 0.158 0.026 CID_3081 | ||
| 0.172 | 0.024 | 0.341 | Bronchodilator | 0.341 0.007 CID_3081 | CID_3081 | |
| 0.148 | 0.006 | 0.148 | Protein kinase C epsilon inhibitor | |||
| 0.151 | 0.01 | 0.293 | Phosphodiesterase III inhibitor | 0.293 0.004 CID_3081 | CID_3081 | |
| 0.233 | 0.101 | 0.233 | Gastrin inhibitor | 0.212 0.13 CID_3081 | ||
| 0.165 | 0.041 | 0.194 | Adenylate cyclase stimulant | 0.194 0.016 CID_3081 | CID_3081 | |
| 0.13 | 0.007 | 0.242 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.242 0.004 CID_3081 | CID_3081 | |
| 0.223 | 0.104 | 0.412 | Spasmolytic | 0.412 0.038 CID_3081 | CID_3081 | |
| 0.134 | 0.017 | 0.221 | HIV-1 reverse transcriptase inhibitor | 0.221 0.008 CID_3081 | CID_3081 | |
| 0.138 | 0.028 | 0.138 | Prolactin inhibitor | 0.113 0.044 CID_3081 | ||
| 0.113 | 0.007 | 0.113 | Elastase inhibitor | 0.1 0.01 CID_3081 | ||
| 0.113 | 0.009 | 0.343 | Phosphodiesterase 3B inhibitor | 0.343 0.003 CID_3081 | CID_3081 | |
| 0.251 | 0.146 | 0.328 | Calcium channel activator | 0.328 0.066 CID_3081 | CID_3081 | |
| 0.108 | 0.007 | 0.108 | Glutamate (mGluR7) antagonist | 0.073 0.037 CID_3081 | ||
| 0.106 | 0.009 | 0.106 | Progesterone antagonist | 0.062 0.014 CID_3081 | ||
| 0.104 | 0.006 | 0.104 | Glutamate (mGluR5) agonist | 0.086 0.009 CID_3081 | ||
| 0.104 | 0.008 | 0.104 | Glutamate (mGluR group I) agonist | 0.092 0.01 CID_3081 | ||
| 0.158 | 0.064 | 0.178 | GABA C receptor rho-2 antagonist | 0.178 0.044 CID_3081 | CID_3081 | |
| 0.108 | 0.016 | 0.108 | Acetylcholine M5 receptor agonist | 0.089 0.027 CID_3081 | ||
| 0.117 | 0.025 | 0.117 | Bromodomain-containing protein 2 inhibitor | 0.117 0.025 CID_3081 | ||
| 0.229 | 0.14 | 0.229 | Cholesterol antagonist | 0.22 0.148 CID_3081 | ||
| 0.183 | 0.096 | 0.183 | Histone acetyltransferase inhibitor | |||
| 0.112 | 0.037 | 0.14 | Triose-phosphate isomerase inhibitor | 0.14 0.023 CID_3081 | CID_3081 | |
| 0.169 | 0.096 | 0.169 | Anesthetic general | 0.137 0.129 CID_3081 | ||
| 0.095 | 0.022 | 0.118 | Carbamoyl phosphate synthetase inhibitor | 0.118 0.016 CID_3081 | CID_3081 | |
| 0.161 | 0.091 | 0.161 | Lipocortins synthesis antagonist | |||
| 0.112 | 0.049 | 0.156 | UDP-glucose 4-epimerase inhibitor | 0.156 0.027 CID_3081 | CID_3081 | |
| 0.139 | 0.077 | 0.139 | Pregnane X receptor agonist | 0.127 0.108 CID_3081 | ||
| 0.15 | 0.088 | 0.163 | Arachidonic acid antagonist | 0.163 0.073 CID_3081 | CID_3081 | |
| 0.067 | 0.008 | 0.303 | Prostaglandin EP3 antagonist | 0.303 0.003 CID_3081 | CID_3081 | |
| 0.161 | 0.101 | 0.161 | P-glycoprotein inhibitor | |||
| 0.081 | 0.022 | 0.081 | Calcium channel T-type blocker | |||
| 0.07 | 0.012 | 0.081 | Adenylate cyclase 1 inhibitor | 0.081 0.007 CID_3081 | CID_3081 | |
| 0.132 | 0.075 | 0.132 | Calcium channel blocker | |||
| 0.138 | 0.082 | 0.138 | Heat shock protein 70 antagonist | 0.13 0.123 CID_3081 | ||
| 0.101 | 0.046 | 0.108 | Androgen antagonist | 0.108 0.041 CID_3081 | CID_3081 | |
| 0.076 | 0.021 | 0.076 | Protein 50S ribosomal subunit inhibitor | 0.064 0.028 CID_3081 | ||
| 0.06 | 0.007 | 0.06 | Calcitonin gene-related peptide antagonist | 0.053 0.009 CID_3081 | ||
| 0.131 | 0.079 | 0.131 | Nav1.6 sodium channel blocker | 0.131 0.079 CID_3081 | ||
| 0.151 | 0.1 | 0.193 | ATPase inhibitor | 0.193 0.043 CID_3081 | CID_3081 | |
| 0.098 | 0.046 | 0.098 | Acetylcholine M3 receptor agonist | 0.077 0.064 CID_3081 | ||
| 0.155 | 0.104 | 0.18 | Succinate dehydrogenase inhibitor | 0.18 0.067 CID_3081 | CID_3081 | |
| 0.106 | 0.055 | 0.11 | Anabolic | 0.11 0.05 CID_3081 | CID_3081 | |
| 0.063 | 0.015 | 0.063 | Carnitine palmitoyltransferase 1B inhibitor | 0.051 0.028 CID_3081 | ||
| 0.076 | 0.03 | 0.094 | Glutamate (mGluR6) antagonist | 0.094 0.013 CID_3081 | CID_3081 | |
| 0.095 | 0.05 | 0.118 | NADH dehydrogenase inhibitor | 0.118 0.03 CID_3081 | CID_3081 | |
| 0.133 | 0.09 | 0.771 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.771 0.003 CID_3081 | CID_3081 | |
| 0.07 | 0.03 | 0.07 | Androgen agonist | 0.066 0.034 CID_3081 | ||
| 0.108 | 0.069 | 0.108 | Cystathionine beta-synthase inhibitor | |||
| 0.165 | 0.126 | 0.167 | Aldehyde oxidase inhibitor | 0.167 0.125 CID_3081 | CID_3081 | |
| 0.268 | 0.231 | 0.282 | Caspase 9 stimulant | 0.282 0.215 CID_3081 | CID_3081 | |
| 0.109 | 0.071 | 0.109 | Calcium channel (voltage-sensitive) blocker | |||
| 0.08 | 0.043 | 0.08 | Lipase inhibitor | |||
| 0.052 | 0.017 | 0.052 | Renin inhibitor | |||
| 0.101 | 0.066 | 0.119 | Adenylate kinase inhibitor | 0.119 0.044 CID_3081 | CID_3081 | |
| 0.097 | 0.062 | 0.104 | Electrolyte absorption antagonist | 0.104 0.053 CID_3081 | CID_3081 | |
| 0.06 | 0.026 | 0.064 | Alpha-mannosidase inhibitor | 0.064 0.022 CID_3081 | CID_3081 | |
| 0.084 | 0.051 | 0.097 | Glycine receptor antagonist | 0.097 0.035 CID_3081 | CID_3081 | |
| 0.082 | 0.049 | 0.084 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 CID_3081 | CID_3081 | |
| 0.104 | 0.071 | 0.146 | Protein kinase C gamma inhibitor | 0.146 0.034 CID_3081 | CID_3081 | |
| 0.065 | 0.033 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.056 | 0.025 | 0.082 | Bromodomain-containing protein 3 inhibitor | 0.082 0.008 CID_3081 | CID_3081 | |
| 0.108 | 0.077 | 0.124 | Microtubule formation inhibitor | 0.124 0.056 CID_3081 | CID_3081 | |
| 0.061 | 0.032 | 0.067 | Acyl-CoA dehydrogenase inhibitor | 0.067 0.029 CID_3081 | CID_3081 | |
| 0.124 | 0.096 | 0.279 | Peroxidase inhibitor | 0.279 0.041 CID_3081 | CID_3081 | |
| 0.083 | 0.056 | 0.083 | Estrogen-related receptor beta agonist | |||
| 0.033 | 0.006 | 0.033 | Acid ceramidase inhibitor | 0.026 0.015 CID_3081 | ||
| 0.2 | 0.176 | 0.2 | Vasodilator, peripheral | |||
| 0.172 | 0.148 | 0.229 | Nitric-oxide synthase stimulant | 0.229 0.05 CID_3081 | CID_3081 | |
| 0.07 | 0.048 | 0.09 | Phosphofructokinase-1 inhibitor | 0.09 0.036 CID_3081 | CID_3081 | |
| 0.095 | 0.073 | 0.185 | GABA C receptor agonist | 0.185 0.023 CID_3081 | CID_3081 | |
| 0.061 | 0.039 | 0.094 | Biliverdin reductase inhibitor | 0.094 0.02 CID_3081 | CID_3081 | |
| 0.065 | 0.044 | 0.065 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.044 CID_3081 | ||
| 0.091 | 0.071 | 0.091 | Creatine kinase inhibitor | 0.083 0.082 CID_3081 | ||
| 0.156 | 0.136 | 0.156 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.049 | 0.03 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.024 CID_3081 | CID_3081 | |
| 0.067 | 0.048 | 0.067 | MDM2 inhibitor | |||
| 0.05 | 0.032 | 0.064 | HCV NS3/NS4A protease inhibitor | 0.064 0.018 CID_3081 | CID_3081 | |
| 0.055 | 0.038 | 0.055 | Acetylcholine muscarinic agonist | |||
| 0.028 | 0.014 | 0.028 | Toll-Like receptor 4 agonist | 0.027 0.016 CID_3081 | ||
| 0.07 | 0.056 | 0.086 | Glutamate dehydrogenase inhibitor | 0.086 0.04 CID_3081 | CID_3081 | |
| 0.098 | 0.084 | 0.098 | Anesthetic local | |||
| 0.07 | 0.055 | 0.071 | Glycine receptor agonist | 0.071 0.052 CID_3081 | CID_3081 | |
| 0.097 | 0.083 | 0.137 | GABA C receptor antagonist | 0.137 0.038 CID_3081 | CID_3081 | |
| 0.038 | 0.024 | 0.038 | Delayed rectifier potassium channel blocker | |||
| 0.168 | 0.155 | 0.172 | 5 Hydroxytryptamine release stimulant | 0.172 0.15 CID_3081 | CID_3081 | |
| 0.125 | 0.113 | 0.173 | Growth hormone agonist | 0.173 0.071 CID_3081 | CID_3081 | |
| 0.113 | 0.101 | 0.113 | Protein kinase stimulant | |||
| 0.043 | 0.034 | 0.05 | Mannosidase inhibitor | 0.05 0.025 CID_3081 | CID_3081 | |
| 0.09 | 0.081 | 0.09 | Falcipain 3 inhibitor | |||
| 0.04 | 0.032 | 0.04 | Acetylcholine M1 receptor agonist | |||
| 0.093 | 0.085 | 0.093 | 5 Hydroxytryptamine 3A agonist | |||
| 0.054 | 0.047 | 0.059 | Pregnane X receptor antagonist | 0.059 0.033 CID_3081 | CID_3081 | |
| 0.051 | 0.047 | 0.065 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.065 0.03 CID_3081 | CID_3081 | |
| 0.046 | 0.041 | 0.046 | Cytokine production stimulant | 0.046 0.042 CID_3081 | ||
| 0.036 | 0.032 | 0.036 | Substance P antagonist | |||
| 0.044 | 0.04 | 0.044 | Cholesterol esterase inhibitor | |||
| 0.012 | 0.008 | 0.012 | 3C-Like protease (MERS coronavirus) inhibitor | |||
| 0.059 | 0.056 | 0.073 | Beta 2 adrenoreceptor agonist | 0.073 0.014 CID_3081 | CID_3081 | |
| 0.087 | 0.084 | 0.114 | GABA C receptor rho-1 antagonist | 0.114 0.046 CID_3081 | CID_3081 | |
| 0.038 | 0.036 | 0.064 | Leukocyte elastase inhibitor | 0.064 0.017 CID_3081 | CID_3081 | |
| 0.069 | 0.068 | 0.069 | Vanilloid 4 agonist | |||
| 0.027 | 0.026 | 0.027 | Glutamate (mGluR2) antagonist | |||
| 0.026 | 0.027 | 0.027 | Acetylcholine M4 receptor agonist | 0.027 0.025 CID_3081 | CID_3081 | |
| 0.014 | 0.016 | 0.025 | Progesterone agonist | 0.025 0.009 CID_3081 | CID_3081 | |
| 0.028 | 0.033 | 0.035 | Fumarate hydratase inhibitor | 0.035 0.023 CID_3081 | CID_3081 | |
| 0.079 | 0.084 | 0.119 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.119 0.04 CID_3081 | CID_3081 | |
| 0.128 | 0.137 | 0.229 | Psychostimulant | 0.229 0.066 CID_3081 | CID_3081 | |
| 0.055 | 0.067 | 0.069 | Syk tyrosine kinase inhibitor | 0.069 0.05 CID_3081 | CID_3081 | |
| 0.086 | 0.101 | 0.113 | Mucolytic | 0.113 0.061 CID_3081 | CID_3081 | |
| 0.034 | 0.052 | 0.044 | Kainate receptor agonist | 0.044 0.023 CID_3081 | CID_3081 | |
| 0.122 | 0.14 | 0.16 | CF transmembrane conductance regulator agonist | 0.16 0.059 CID_3081 | CID_3081 | |
| 0.015 | 0.035 | 0.02 | Glutamate (mGluR1a) agonist | 0.02 0.018 CID_3081 | CID_3081 | |
| 0.041 | 0.062 | 0.068 | Argininosuccinate synthase inhibitor | 0.068 0.031 CID_3081 | CID_3081 | |
| 0.048 | 0.073 | 0.524 | Peroxisome proliferator-activated receptor gamma agonist | 0.524 0.003 CID_3081 | CID_3081 | |
| 0.071 | 0.098 | 0.078 | mTOR complex 2 inhibitor | 0.078 0.076 CID_3081 | CID_3081 | |
| 0.084 | 0.112 | 0.12 | Alkylator | 0.12 0.068 CID_3081 | CID_3081 | |
| 0.012 | 0.044 | 0.026 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.026 0.021 CID_3081 | CID_3081 | |
| 0.013 | 0.046 | 0.094 | Elastase 2A inhibitor | 0.094 0.003 CID_3081 | CID_3081 | |
| 0.013 | 0.046 | 0.094 | Elastase 2 inhibitor | 0.094 0.003 CID_3081 | CID_3081 | |
| 0.05 | 0.083 | 0.08 | Porphobilinogen synthase inhibitor | 0.08 0.047 CID_3081 | CID_3081 | |
| 0.049 | 0.083 | 0.064 | Catalase inhibitor | 0.064 0.061 CID_3081 | CID_3081 | |
| 0.129 | 0.163 | 0.217 | Insulin sensitizer | 0.217 0.057 CID_3081 | CID_3081 | |
| 0.072 | 0.109 | 0.094 | Expectorant | 0.094 0.076 CID_3081 | CID_3081 | |
| 0.035 | 0.075 | 0.058 | Alcohol oxidase inhibitor | 0.058 0.037 CID_3081 | CID_3081 | |
| 0.038 | 0.08 | 0.071 | NMDA receptor glycine site agonist | 0.071 0.035 CID_3081 | CID_3081 | |
| 0.194 | 0.236 | 0.29 | Antibacterial | 0.29 0.143 CID_3081 | CID_3081 | |
| 0.02 | 0.066 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 CID_3081 | CID_3081 | |
| 0.015 | 0.063 | 0.034 | Retinoid X receptor agonist | 0.034 0.026 CID_3081 | CID_3081 | |
| 0.015 | 0.064 | 0.027 | Nicotinic acid receptor 2 antagonist | 0.027 0.017 CID_3081 | CID_3081 | |
| 0.166 | 0.216 | 0.236 | Insulysin inhibitor | 0.236 0.11 CID_3081 | CID_3081 | |
| 0.024 | 0.076 | 0.043 | Glutamate (mGluR1a) antagonist | 0.043 0.027 CID_3081 | CID_3081 | |
| 0.087 | 0.139 | 0.114 | Cathepsin H inhibitor | 0.114 0.083 CID_3081 | CID_3081 | |
| 0.131 | 0.184 | 0.169 | Interleukin agonist | 0.169 0.149 CID_3081 | CID_3081 | |
| 0.109 | 0.162 | 0.129 | Melanin inhibitor | 0.129 0.116 CID_3081 | CID_3081 | |
| 0.098 | 0.155 | 0.115 | Vanilloid 1 agonist | 0.115 0.1 CID_3081 | CID_3081 | |
| 0.084 | 0.141 | 0.155 | Lipid peroxidase inhibitor | 0.155 0.065 CID_3081 | CID_3081 | |
| 0.165 | 0.228 | 0.203 | Antithrombotic | 0.203 0.173 CID_3081 | CID_3081 | |
| 0.053 | 0.116 | 0.068 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.068 0.064 CID_3081 | CID_3081 | |
| 0.109 | 0.173 | 0.136 | MAP kinase 3 inhibitor | 0.136 0.093 CID_3081 | CID_3081 | |
| 0.04 | 0.107 | 0.058 | NMDA receptor agonist | 0.058 0.051 CID_3081 | CID_3081 | |
| 0.047 | 0.114 | 0.087 | Phospholipase D inhibitor | 0.087 0.026 CID_3081 | CID_3081 | |
| 0.054 | 0.125 | 0.087 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.087 0.061 CID_3081 | CID_3081 | |
| 0.031 | 0.103 | 0.047 | Potassium channel (ATP-sensitive) activator | 0.047 0.036 CID_3081 | CID_3081 | |
| 0.033 | 0.105 | 0.049 | Potassium channel (Inward rectifier) activator | 0.049 0.038 CID_3081 | CID_3081 | |
| 0.089 | 0.162 | 0.506 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.506 0.005 CID_3081 | CID_3081 | |
| 0.051 | 0.125 | 0.071 | Peroxisome proliferator-activated receptor gamma antagonist | 0.071 0.05 CID_3081 | CID_3081 | |
| 0.105 | 0.191 | 0.129 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.129 0.119 CID_3081 | CID_3081 | |
| 0.017 | 0.105 | 0.051 | Peroxisome proliferator-activated receptor alpha agonist | 0.051 0.031 CID_3081 | CID_3081 | |
| 0.06 | 0.156 | 0.08 | Granulocyte macrophage colony stimulating factor agonist | 0.08 0.075 CID_3081 | CID_3081 | |
| 0.1 | 0.204 | 0.164 | I kappa B kinase epsilon inhibitor | 0.164 0.105 CID_3081 | CID_3081 | |
| 0.03 | 0.142 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.039 CID_3081 | CID_3081 | |
| 0.02 | 0.134 | 0.057 | NMDA 2C receptor antagonist | 0.057 0.05 CID_3081 | CID_3081 | |
| 0.059 | 0.174 | 0.165 | Amylase inhibitor | 0.165 0.057 CID_3081 | CID_3081 | |
| 0.019 | 0.148 | 0.058 | Dihydroorotase inhibitor | 0.058 0.018 CID_3081 | CID_3081 | |
| 0.084 | 0.222 | 0.227 | Polo-like kinase-3 inhibitor | 0.227 0.033 CID_3081 | CID_3081 | |
| 0.051 | 0.203 | 0.089 | Xanthine oxidase inhibitor | 0.089 0.074 CID_3081 | CID_3081 | |
| 0.036 | 0.198 | 0.077 | Adrenaline agonist | 0.077 0.062 CID_3081 | CID_3081 | |
| 0.014 | 0.181 | 0.115 | Prostaglandin E2 antagonist | 0.115 0.012 CID_3081 | CID_3081 | |
| 0.07 | 0.24 | 0.41 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.41 0.01 CID_3081 | CID_3081 | |
| 0.072 | 0.289 | 0.138 | Hemostatic | 0.138 0.084 CID_3081 | CID_3081 | |
| 0.03 | 0.275 | 0.099 | Polo-like kinase-4 inhibitor | 0.099 0.079 CID_3081 | CID_3081 | |
| 0.053 | 0.335 | 0.307 | Hypolipemic | 0.307 0.047 CID_3081 | CID_3081 | |
| 0.03 | 0.319 | 0.059 | Kallikrein 1 inhibitor | 0.059 0.036 CID_3081 | CID_3081 | |
| 0.067 | 0.384 | 0.208 | Calpain 2 inhibitor | 0.208 0.181 CID_3081 | CID_3081 | |
| 0.054 | 0.378 | 0.166 | Calpain inhibitor | 0.166 0.154 CID_3081 | CID_3081 | |
| 0.117 | 0.523 | 0.324 | Calcium channel L-type activator | 0.324 0.137 CID_3081 | CID_3081 | |
| 0.038 | 0.478 | 0.258 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.258 0.054 CID_3081 | CID_3081 | |
| 0.015 | 0.463 | 0.09 | EphA2 antagonist | 0.09 0.087 CID_3081 | CID_3081 | |
| 0.006 | 0.462 | 0.062 | NMDA 2B receptor antagonist | 0.062 0.03 CID_3081 | CID_3081 | |
| 0.024 | 0.488 | 0.178 | TRKC antagonist | 0.178 0.08 CID_3081 | CID_3081 | |
| 0.023 | 0.506 | 0.322 | Death-associated protein kinase 3 inhibitor | 0.322 0.032 CID_3081 | CID_3081 | |
| 0.015 | 0.525 | 0.241 | Protein kinase C nu inhibitor | 0.241 0.036 CID_3081 | CID_3081 | |
| 0.019 | 0.542 | 0.104 | MAP kinase 13 inhibitor | 0.104 0.075 CID_3081 | CID_3081 | |
| 0.005 | 0.534 | 0.088 | Peroxisome proliferator-activated receptor delta antagonist | 0.088 0.006 CID_3081 | CID_3081 | |
| 0.005 | 0.546 | 0.05 | Aldose reductase inhibitor | 0.05 0.039 CID_3081 | CID_3081 | |
| 0.023 | 0.724 | 0.259 | Toll-Like receptor agonist | 0.259 0.141 CID_3081 | CID_3081 | |
| 0.022 | 0.736 | 0.242 | Toll-Like receptor 7 agonist | 0.242 0.154 CID_3081 | CID_3081 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |